Connect with us

Technology

HealthVerity recognized in three 2023 Gartner® Hype Cycle™ reports

Published

3 years ago

on

Recognized for Life Science Clinical Development, Life Science Commercial Operations, and Healthcare Data, Analytics and AI 

PHILADELPHIA, Feb. 13, 2024 /PRNewswire/ — HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, today announced that it was recognized in three of the July 2023 Gartner Hype Cycles titled: Hype Cycle for Life Science Clinical Development, 2023, Hype Cycle for Life Science Commercial Operations, 2023, and Hype Cycle for Healthcare Data, Analytics and AI, 2023. This is the second year in a row that the company has been recognized in all three of these Hype Cycles and the third consecutive year for Life Science Commercial Operations.

HealthVerity was recognized as a vendor providing several different technology solutions in each of the three Hype Cycles:

Life Science Clinical DevelopmentPatient data tokenization – According to Gartner, “Patient data tokenization is the process by which clinical trial subjects/patients consent to have their anonymized health information linked to a subject identifier or token. The token can also be linked to existing real-world data (RWD) sources like healthcare claims and laboratory results. This enables life science companies to link patients who have consented to their retrospective RWD, following their activities prospectively for ongoing insights about branded treatments on patient health.” The Gartner report found that this technology is important because, “Patient data tokenization (PDT) enables patient data to be connected between different data sources, enabling life science companies to formulate a holistic, longitudinal view of the patient journey. RWD made available via tokenization can provide significant insight about patient health history, enabling insights about outcomes after a trial, intervention or treatment has been administered by a life science company.” 

RWD-based trials – “Real-world data (RWD)-based trials use RWD to optimize trial activities with applications that deliver improvements to patient recruitment and retention, protocol optimization, trial feasibility, and safety signal detection. As RWD becomes more available, life science companies and vendors are leveraging it to support effective protocol design, precision methods of finding subjects to successfully complete the trial, and improved data capture that leverages patient health records.”

Data monetization in HCLS – “Data monetization is a practice adopted by a healthcare and life science (HCLS) organization by which they make their proprietary data available to sell to external parties. The most mature examples are payers selling deidentified medical claims data to life science companies. This profile tracks monetization of new data types, utilizing new sharing mechanisms and vendors, targeted at new use cases, which are driving a new cycle of data monetization initiatives.” 

Life Science Commercial OperationsRWD curation and analytics platforms – According to Gartner, “This technology combines real-world data (RWD), such as electronic health records (EHR), medical and prescription claims, disease and patient registries, lab results, imaging and other sources, to provide a longitudinal view of a patient journey. The platform prepares data for delivery to downstream consumption platforms, applications and analytics. It automates the ingestion and linking of data from permissioned sources, manages identity, compliance and security.”

Healthcare Data, Analytics and AIData sharing in HCLS – “Data sharing in healthcare and life science (HCLS) reflects a broad range of use cases that knit together ecosystem partners to advance clinical care, research and discovery; improve public health; decrease health disparities; and lower costs. Data sharing in HCLS relies on a foundation of interoperability, privacy protecting policies and standards to enable the industry to safely and collaboratively drive new value streams through better data sharing partnerships.”

Data monetization in HCLS – Defined by Gartner as, “a practice adopted by a healthcare and life science (HCLS) organization by which they make their proprietary data available to sell to external parties. The most mature examples are payers selling deidentified medical claims data to life science companies. This profile tracks monetization of new data types, utilizing new sharing mechanisms and vendors, targeted at new use cases, which are driving a new cycle of data monetization initiatives.”

HealthVerity offers patient data tokenization services with HealthVerity Identity Manager, a leading patient matching and identity resolution technology that is 10x more accurate than legacy tokenization technologies. Identity Manager establishes a unique but persistent HealthVerity ID (HVID) to resolve patient identity over time and across data sources to create a fully interoperable single source of truth. HealthVerity FLOW is a middleware solution that can enable RWD-based clinical trials and be used as a RWD curation and analytics platform that leverages this source of truth capability to enable RWD-driven patient journey initiatives. For example, the platform can synchronize clinical trial participants, their permissions, and the broadest set of identifiable and de-identified data sources in a fully governed, HIPAA-compliant manner to accelerate the time to FDA submission. Additionally, HealthVerity offers data owners the ability to join the nation’s largest healthcare and consumer data ecosystem while managing all aspects of identity resolution, privacy protection and governance of data usage rights for the seamless exchange of unlimited real-world data on HealthVerity Marketplace.

“We are excited to be recognized by Gartner in the Hype Cycle reports,” said HealthVerity COO Andrew Goldberg. “We pride ourselves on offering the life sciences and healthcare sectors transformational technologies that synchronize unparalleled identity management with built-in privacy compliance and governance of data usage rights for the seamless exchange of a near limitless combination of healthcare and consumer data. We believe our inclusion in the Gartner Hype Cycle reports demonstrates the difference these solutions can have on advancing the science.”

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

Gartner Disclaimer
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About HealthVerity
HealthVerity synchronizes transformational technologies with the nation’s largest healthcare and consumer data ecosystem to power previously unattainable outcomes and fundamentally advance the science. We offer a comprehensive, yet flexible approach, based on the foundational elements of Identity, Privacy, Governance and Exchange (IPGE), that synchronizes unparalleled Identity management with built-in Privacy compliance and Governance, providing the ability to discover and Exchange a near limitless combination of data at a record pace. Together with our partners in life sciences, government and insurance, we are Synchronizing the Science. To learn more about HealthVerity, visit healthverity.com.

HealthVerity Contact:
Colleen Stoker
614-738-0592
cstoker@healthverity.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/healthverity-recognized-in-three-2023-gartner-hype-cycle-reports-302059926.html

SOURCE HealthVerity

Related Topics:
Continue Reading

Technology

Eqvista Launches Company-Sponsored Tender Offers, Expanding Private Market Liquidity Capabilities

Published

36 minutes ago

on

October 19, 2026

By

New tender offer capabilities connect equity management with real-time valuation data covering approximately 65,000 private companies with a combined estimated value of $9 trillion, laying the groundwork for future secondary marketplace capabilities.

SAN FRANCISCO, Oct. 19, 2026 /PRNewswire/ — Eqvista, a leading equity management and valuation platform serving more than 25,000 companies, today announced the launch of company-sponsored tender offer capabilities, enabling private companies to organize structured liquidity events directly within their equity management platform. The launch also marks a step toward Eqvista’s planned secondary marketplace capabilities.

As companies stay private longer, employees and early investors face limited opportunities to sell their shares. Meanwhile, organizing liquidity events involves complex decisions around pricing, participant eligibility, approvals, and ownership changes.

Eqvista brings these processes together through a company-controlled tender offer workflow, supported by its equity management infrastructure and Eqvista Real-Time Company Valuation® technology.

“With Eqvista, private companies can help their employees and early investors turn their shares into cash, rewarding them for their contributions to the company,” said Tomas Milar, Founder and CEO of Eqvista. “We already help companies manage ownership and understand their value. Bringing tender offers into the same platform is a natural next step toward connecting equity management, valuation, and liquidity.”

Company-Controlled Tender Offers

Eqvista’s new capabilities allow companies to manage tender offers while maintaining control over participation, transaction terms, and ownership changes.

Key features include:

Cap table integration: Automatically record completed ownership changes.Participant controls: Define eligible buyers and sellers and offer windows.Allocation rules: Set transaction limits, pro rata allocations, and priorities.Integrated approvals: Manage approval requirements and rights of first refusal.Valuation-informed pricing: Reference Eqvista Real-Time Company Valuation® data when evaluating transaction pricing.

By integrating these processes, Eqvista aims to reduce the administrative complexity of organizing liquidity events while helping companies maintain control over their shareholder base.

Building Toward a Secondary Marketplace

Building on its company-sponsored tender offer capabilities, Eqvista plans to expand into secondary marketplace infrastructure designed to support structured, company-approved liquidity programs. By connecting ownership records, real-time valuation data, and private share transactions within one platform, Eqvista aims to make private market liquidity more accessible while allowing companies to maintain control over participation and ownership changes. Further details will be announced as development progresses, subject to applicable regulatory requirements.

Learn more about Eqvista’s Company-Sponsored Tender Offers.

About Eqvista

Eqvista is an equity management and valuation platform building infrastructure for private markets. Trusted by more than 25,000 companies worldwide, Eqvista combines equity management, in-house valuation expertise, and AI-powered technology to help private companies manage ownership and understand their value. Eqvista Real-Time Company Valuation® technology covers approximately 65,000 U.S. private companies representing an estimated $9 trillion in combined value.

Contact Information
Jakub Vele
Head of Marketing
424978@email4pr.com
+1 (415) 375-4963

View original content to download multimedia:https://www.prnewswire.com/news-releases/eqvista-launches-company-sponsored-tender-offers-expanding-private-market-liquidity-capabilities-302911472.html

SOURCE Eqvista

Continue Reading

Technology

Eqvista Launches Company-Sponsored Tender Offers, Expanding Private Market Liquidity Capabilities

Published

36 minutes ago

on

October 19, 2026

By

New tender offer capabilities connect equity management with real-time valuation data covering approximately 65,000 private companies with a combined estimated value of $9 trillion, laying the groundwork for future secondary marketplace capabilities.

SAN FRANCISCO, Oct. 19, 2026 /PRNewswire/ — Eqvista, a leading equity management and valuation platform serving more than 25,000 companies, today announced the launch of company-sponsored tender offer capabilities, enabling private companies to organize structured liquidity events directly within their equity management platform. The launch also marks a step toward Eqvista’s planned secondary marketplace capabilities.

As companies stay private longer, employees and early investors face limited opportunities to sell their shares. Meanwhile, organizing liquidity events involves complex decisions around pricing, participant eligibility, approvals, and ownership changes.

Eqvista brings these processes together through a company-controlled tender offer workflow, supported by its equity management infrastructure and Eqvista Real-Time Company Valuation® technology.

“With Eqvista, private companies can help their employees and early investors turn their shares into cash, rewarding them for their contributions to the company,” said Tomas Milar, Founder and CEO of Eqvista. “We already help companies manage ownership and understand their value. Bringing tender offers into the same platform is a natural next step toward connecting equity management, valuation, and liquidity.”

Company-Controlled Tender Offers

Eqvista’s new capabilities allow companies to manage tender offers while maintaining control over participation, transaction terms, and ownership changes.

Key features include:

Cap table integration: Automatically record completed ownership changes.Participant controls: Define eligible buyers and sellers and offer windows.Allocation rules: Set transaction limits, pro rata allocations, and priorities.Integrated approvals: Manage approval requirements and rights of first refusal.Valuation-informed pricing: Reference Eqvista Real-Time Company Valuation® data when evaluating transaction pricing.

By integrating these processes, Eqvista aims to reduce the administrative complexity of organizing liquidity events while helping companies maintain control over their shareholder base.

Building Toward a Secondary Marketplace

Building on its company-sponsored tender offer capabilities, Eqvista plans to expand into secondary marketplace infrastructure designed to support structured, company-approved liquidity programs. By connecting ownership records, real-time valuation data, and private share transactions within one platform, Eqvista aims to make private market liquidity more accessible while allowing companies to maintain control over participation and ownership changes. Further details will be announced as development progresses, subject to applicable regulatory requirements.

Learn more about Eqvista’s Company-Sponsored Tender Offers.

About Eqvista

Eqvista is an equity management and valuation platform building infrastructure for private markets. Trusted by more than 25,000 companies worldwide, Eqvista combines equity management, in-house valuation expertise, and AI-powered technology to help private companies manage ownership and understand their value. Eqvista Real-Time Company Valuation® technology covers approximately 65,000 U.S. private companies representing an estimated $9 trillion in combined value.

Contact Information
Jakub Vele
Head of Marketing
424978@email4pr.com
+1 (415) 375-4963

View original content to download multimedia:https://www.prnewswire.com/news-releases/eqvista-launches-company-sponsored-tender-offers-expanding-private-market-liquidity-capabilities-302911472.html

SOURCE Eqvista

Continue Reading

Technology

Eqvista Launches Company-Sponsored Tender Offers, Expanding Private Market Liquidity Capabilities

Published

36 minutes ago

on

October 19, 2026

By

New tender offer capabilities connect equity management with real-time valuation data covering approximately 65,000 private companies with a combined estimated value of $9 trillion, laying the groundwork for future secondary marketplace capabilities.

SAN FRANCISCO, Oct. 19, 2026 /PRNewswire/ — Eqvista, a leading equity management and valuation platform serving more than 25,000 companies, today announced the launch of company-sponsored tender offer capabilities, enabling private companies to organize structured liquidity events directly within their equity management platform. The launch also marks a step toward Eqvista’s planned secondary marketplace capabilities.

As companies stay private longer, employees and early investors face limited opportunities to sell their shares. Meanwhile, organizing liquidity events involves complex decisions around pricing, participant eligibility, approvals, and ownership changes.

Eqvista brings these processes together through a company-controlled tender offer workflow, supported by its equity management infrastructure and Eqvista Real-Time Company Valuation® technology.

“With Eqvista, private companies can help their employees and early investors turn their shares into cash, rewarding them for their contributions to the company,” said Tomas Milar, Founder and CEO of Eqvista. “We already help companies manage ownership and understand their value. Bringing tender offers into the same platform is a natural next step toward connecting equity management, valuation, and liquidity.”

Company-Controlled Tender Offers

Eqvista’s new capabilities allow companies to manage tender offers while maintaining control over participation, transaction terms, and ownership changes.

Key features include:

Cap table integration: Automatically record completed ownership changes.Participant controls: Define eligible buyers and sellers and offer windows.Allocation rules: Set transaction limits, pro rata allocations, and priorities.Integrated approvals: Manage approval requirements and rights of first refusal.Valuation-informed pricing: Reference Eqvista Real-Time Company Valuation® data when evaluating transaction pricing.

By integrating these processes, Eqvista aims to reduce the administrative complexity of organizing liquidity events while helping companies maintain control over their shareholder base.

Building Toward a Secondary Marketplace

Building on its company-sponsored tender offer capabilities, Eqvista plans to expand into secondary marketplace infrastructure designed to support structured, company-approved liquidity programs. By connecting ownership records, real-time valuation data, and private share transactions within one platform, Eqvista aims to make private market liquidity more accessible while allowing companies to maintain control over participation and ownership changes. Further details will be announced as development progresses, subject to applicable regulatory requirements.

Learn more about Eqvista’s Company-Sponsored Tender Offers.

About Eqvista

Eqvista is an equity management and valuation platform building infrastructure for private markets. Trusted by more than 25,000 companies worldwide, Eqvista combines equity management, in-house valuation expertise, and AI-powered technology to help private companies manage ownership and understand their value. Eqvista Real-Time Company Valuation® technology covers approximately 65,000 U.S. private companies representing an estimated $9 trillion in combined value.

Contact Information
Jakub Vele
Head of Marketing
424978@email4pr.com
+1 (415) 375-4963

View original content to download multimedia:https://www.prnewswire.com/news-releases/eqvista-launches-company-sponsored-tender-offers-expanding-private-market-liquidity-capabilities-302911472.html

SOURCE Eqvista

Continue Reading

Trending